SlideShare a Scribd company logo
Initial biopsies
can miss one-third
of all prostate
                                                                                                                                            1 6
                                                                                                                                            men will be
                                                                                                                                                       out of
                                                                                                                                                       every

cancers.           2

                                                                                                                                            diagnosed with
Biopsy needles may not hit small tumors,
and biopsy samples may yield inconclusive                                                                                                   prostate cancer.                                  1


results. In both of these situations, no cancer
                                                                                                                                            As men age, their risk for getting prostate
was found, but it may still exist. Based on
                                                                                                                                            cancer increases. However, early detection
your medical history and additional risk
                                                                                                                                            can help physicians better manage their
factors, your doctor may decide to order
                                                                                                                                            patients’ health.
an additional biopsy. However, in many
cases a negative biopsy is truly negative,
and a second biopsy is unnecessary. But                                                                                                     Screening for
how can you and your doctor be more                                                                                                         prostate cancer
confident in the results?
                                                  www.mitomicsinc.com
                                                                                                                                            Your physician will likely use a digital rectal
                                                  PCMTsupport@mitomicsinc.com                                                               examination and prostate-specific antigen (PSA) test

Now there’s an                                    888.763.2644                                                                              to screen for prostate cancer. Irregular or suspicious


easy and pain-free
                                                                                                                                            results, along with your current health and medical
                                                                                                                                            history, may cause your physician to order a

                                                                                                                   What does your
                                                  Prostate Core Mitomic Test or one or more of its components
                                                  was developed and its performance characteristics determined                              prostate biopsy.

way to confirm                                    by Mitomics. It has not been approved by the Food and


                                                                                                                   prostate biopsy
                                                  Drug Administration (FDA). Mitomics has determined that
                                                  such approval is not necessary. This test is used for clinical
                                                                                                                                            Reason for a biopsy
biopsy results.                                   purposes. It should not be regarded as investigational or for
                                                  research. Mitomics is regulated under the Clinical Laboratory
                                                  Improvement Act (CLIA) of 1988 as qualified to perform
                                                  high-complexity clinical testing.                                result really mean?      As of today, a biopsy is the only test that fully
                                                                                                                                            confirms the diagnosis of prostate cancer. Tissue
                                                  © 2012-2013 Mitomics Inc. All rights reserved. Prostate
                                                  Core Mitomic Test, Mitomic, Mitomics, and Empowering                                      samples are taken from your prostate with a needle,
                                                  Clinical Insight are trademarks of Mitomics Inc.
                                                  References: 1. American Cancer Society. 2. American Society
                                                                                                                   With the Prostate Core   and then analyzed to determine the presence or
                                                                                                                                            absence of cancer cells.
                                                  of Clinical Oncology.
                                                                                                                   Mitomic Test™ now you
                                                                                                                                ,
                                                  0201.2013 Rev 2
                                                                                                                   can know.
Why should I believe                                           What do the results mean?                                  How do I pay for the Prostate
                                   the results of the Prostate                                                                                               Core Mitomic Test?
                                                                                                    Negative                      Positive
                                   Core Mitomic Test?                                                                                                        If you have Medicare, you are responsible for any
                                                                                                                                                             applicable deductible and co-payment as required
                                   Unlike the biopsy, which only examines tissue from
                                                                                                                                                             by federal insurance regulations. Co-pays are
                                   specific areas of the prostate, the Prostate Core
                                                                                                                                                             20-percent of the Medicare allowable.
                                   Mitomic Test can identify abnormalities in cells that

The Prostate                       are near tumors, not just in the tumors themselves.
                                   The Prostate Core Mitomic Test works by recognizing
                                                                                                    A negative PCMT result        A positive PCMT result     For commercial insurance, Mitomics accepts the
                                                                                                                                                             insurer’s contracted allowed amount for the Prostate

Core Mitomic Test
                                                                                                    confirms the negative         means you are at a high
                                   changes in your mitochondrial DNA. Mitochondria are              result of your biopsy. With   risk for undiagnosed       Core Mitomic Test as payment in full. Please note that
                                   structures within a cell that produce energy for the cell.       a high degree of certainty,   prostate cancer. Your      Mitomics is not currently a participating provider with

(PCMT™) examines                   Mitochondrial DNA is highly susceptible to damage.               PCMT identifies that you      doctor can use this
                                                                                                                                                             all insurers. If your insurance company denies coverage
                                                                                                    do not currently have         information to tailor
                                   The Prostate Core Mitomic Test identifies the damage                                                                      because Mitomics is out of network, Mitomics will
                                                                                                    prostate cancer. Because      a treatment based on

tissue taken from                  to mitochondrial DNA caused by cellular changes
                                   associated with prostate cancer development.
                                                                                                    an additional biopsy is not   your personal situation.   work with you directly to appeal the claim. You will be
                                                                                                                                                             responsible for your normal co-pay, deductibles, and/or

your biopsy. You
                                                                                                    needed, you can avoid         By knowing your risk
                                                                                                    extra pain and anxiety –      earlier, you can make      co-insurance requirements as identified by your plan.
                                   The Prostate Core Mitomic Test is a highly sensitive             and have peace of mind        more informed decisions


do not need to
                                   test that can pick out this damage in normal cells               that you are prostate         concerning your health.    The explanation of benefits (EOB) is not a bill. Do not
                                   that are adjacent to tumors. As you can see in the               cancer free today.                                       make a payment to Mitomics upon receipt of an EOB.


have any additional
                                   diagram, the cancerous tumor can be quite small,                                                                          You will be billed in accordance to the billing policy
                                   and the biopsy cores may not come in contact with                                                                         noted above – not the amounts stated on the EOB.
                                                                                                  When will I receive
surgeries or even
                                   the tumor. However, the Prostate Core Mitomic Test
                                                                                                                                                             If you receive insurance proceeds directly, these
                                   can identify the presence of the tumor because the
                                                                                                  the results?                                               proceeds must be forwarded to Mitomics to settle

a doctor’s visit.
                                   mitochondrial DNA in the tissue throughout the prostate
                                   could indicate changes at the cellular level.                  Your doctor will order the Prostate Core Mitomic           the billed amount. Mitomics does not use a collection

                                                                                                  Test when your biopsy is submitted for evaluation.         agency; however, in this circumstance, you will

                                                                                                  A special lab processes your biopsy tissue, and            receive a letter from Mitomics asking that you forward
                                                              BLADDER                             the results will be sent to your doctor. Your doctor       proceeds to Mitomics.

                                                                                                  will then contact you to discuss the results.
                                     TUMOR
                                                                                       PROSTATE
                                                                                                                                                             If you have any questions concerning billing, health care
                                      FIELD
                                     EFFECT                                                                                                                  coverage, or payment for the Prostate Core Mitomic Test,
                                                                                                                                                             please contact:

 If you have any questions about   BIOPSY CORE
                                                                                                                                                             GGB Medical Management Services, Inc.
 the Prostate Core Mitomic Test                                                     TUMOR
                                                                                                                                                             PO Box 2311

 or your biopsy results, talk to                                                                                                                             Chatsworth, CA 91313-2311

 your doctor.                                                                                                                                                www.ggbmedical.com             818.718.9519 Spanish
                                                                         URETHRA
                                                                                                                                                             800.718.9505 Toll-free         818.718.9507 Fax

More Related Content

What's hot

Asco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_finalAsco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_finalJames Hilbert
 
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...European School of Oncology
 
Advanced prostate cancer - Non CRPC
Advanced prostate cancer - Non CRPCAdvanced prostate cancer - Non CRPC
Advanced prostate cancer - Non CRPC
Mohamed Abdulla
 
DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)
PCRI_2012conf
 
NET Theranostics Research Poster
NET Theranostics Research PosterNET Theranostics Research Poster
NET Theranostics Research PosterIan Alexander
 
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Gastrolearning
 
Oncology Big Data: A Mirage or Oasis of Clinical Value?
Oncology Big Data:  A Mirage or Oasis of Clinical Value? Oncology Big Data:  A Mirage or Oasis of Clinical Value?
Oncology Big Data: A Mirage or Oasis of Clinical Value?
Michael Peters
 
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
Institute For Medical Education and Research (IMER)
 
SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”
Sri Lanka College of Sexual Health and HIV Medicine
 
Gut talk
Gut talkGut talk
Gut talk
madurai
 
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...European School of Oncology
 
EpiGene request for partnership
EpiGene request for partnershipEpiGene request for partnership
EpiGene request for partnership
Евгений Дубинин
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
ES-Teck India
 
New Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial CarcinomaNew Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial Carcinoma
i3 Health
 
Hormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerHormone Resistant Prostate Cancer
Hormone Resistant Prostate Cancer
Santam Chakraborty
 
Prostate cancer
Prostate cancer   Prostate cancer
Prostate cancer
Mohamed Abdulla
 
Intravesical Therapy: Old trials, new agents and new approaches
Intravesical Therapy: Old trials, new agents and new approaches Intravesical Therapy: Old trials, new agents and new approaches
Intravesical Therapy: Old trials, new agents and new approaches
BJUI
 

What's hot (18)

Asco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_finalAsco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_final
 
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...
Endoscopy in Gastrointestinal Oncology - Slide 9 - P.G. Arcidiacono - EUS in ...
 
Advanced prostate cancer - Non CRPC
Advanced prostate cancer - Non CRPCAdvanced prostate cancer - Non CRPC
Advanced prostate cancer - Non CRPC
 
DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)DrLam HighRiskProstateCancer(Azure)
DrLam HighRiskProstateCancer(Azure)
 
NET Theranostics Research Poster
NET Theranostics Research PosterNET Theranostics Research Poster
NET Theranostics Research Poster
 
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
 
Oncology Big Data: A Mirage or Oasis of Clinical Value?
Oncology Big Data:  A Mirage or Oasis of Clinical Value? Oncology Big Data:  A Mirage or Oasis of Clinical Value?
Oncology Big Data: A Mirage or Oasis of Clinical Value?
 
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
Expert Video Viewpoints on Castration-Resistant Prostate Cancer: Care Across ...
 
SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”SS 2017: Mycoplasma genitalium :“Status in South Asia”
SS 2017: Mycoplasma genitalium :“Status in South Asia”
 
Gut talk
Gut talkGut talk
Gut talk
 
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...
NY Prostate Cancer Conference - C. Bangma - Session 3: Predicting indolent an...
 
EpiGene request for partnership
EpiGene request for partnershipEpiGene request for partnership
EpiGene request for partnership
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
 
Pet and gbm
Pet and gbmPet and gbm
Pet and gbm
 
New Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial CarcinomaNew Thinking, New Strategies in Advanced Urothelial Carcinoma
New Thinking, New Strategies in Advanced Urothelial Carcinoma
 
Hormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerHormone Resistant Prostate Cancer
Hormone Resistant Prostate Cancer
 
Prostate cancer
Prostate cancer   Prostate cancer
Prostate cancer
 
Intravesical Therapy: Old trials, new agents and new approaches
Intravesical Therapy: Old trials, new agents and new approaches Intravesical Therapy: Old trials, new agents and new approaches
Intravesical Therapy: Old trials, new agents and new approaches
 

Similar to PCMT Patient Brochure Feb 2013

PCMT Product Sheet June 2012
PCMT Product Sheet June 2012PCMT Product Sheet June 2012
PCMT Product Sheet June 2012Chris Merritt
 
PCMT Technical Summary Whitepaper April 2013
PCMT Technical Summary Whitepaper April 2013PCMT Technical Summary Whitepaper April 2013
PCMT Technical Summary Whitepaper April 2013Chris Merritt
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012
Aieme Uam
 
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...nataliejleigh
 
Cancer biomarker
Cancer biomarkerCancer biomarker
Cancer biomarker
KEERTHANAV34
 
Cancer biomarker
Cancer biomarkerCancer biomarker
Cancer biomarker
keerthanav36
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
Robert J Miller MD
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
JohnJulie1
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
AnonIshanvi
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
EditorSara
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
NainaAnon
 
Placebo in cancer
Placebo in cancerPlacebo in cancer
Placebo in cancerpharma_avik
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
daranisaha
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
semualkaira
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
semualkaira
 
Prostate Cancer 2013
Prostate Cancer 2013Prostate Cancer 2013
Prostate Cancer 2013
Robert J Miller MD
 

Similar to PCMT Patient Brochure Feb 2013 (20)

PCMT Product Sheet June 2012
PCMT Product Sheet June 2012PCMT Product Sheet June 2012
PCMT Product Sheet June 2012
 
PCMT Technical Summary Whitepaper April 2013
PCMT Technical Summary Whitepaper April 2013PCMT Technical Summary Whitepaper April 2013
PCMT Technical Summary Whitepaper April 2013
 
Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012Screening for Prostate Cancer NEJM cases 2012
Screening for Prostate Cancer NEJM cases 2012
 
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
Prostate Cancer Testing & Surgical Options - By Peter J Gilling http://www.ur...
 
Cancer biomarker
Cancer biomarkerCancer biomarker
Cancer biomarker
 
Cancer biomarker
Cancer biomarkerCancer biomarker
Cancer biomarker
 
Module 5 Dr Scholz-Screening&Biopsy
Module 5 Dr Scholz-Screening&BiopsyModule 5 Dr Scholz-Screening&Biopsy
Module 5 Dr Scholz-Screening&Biopsy
 
Tumor detecting app
Tumor detecting appTumor detecting app
Tumor detecting app
 
What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021What’s new in prostate cancer part 1, 2021
What’s new in prostate cancer part 1, 2021
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Placebo in cancer
Placebo in cancerPlacebo in cancer
Placebo in cancer
 
Breastexam
BreastexamBreastexam
Breastexam
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Principles of Cancer Screening
Principles of Cancer ScreeningPrinciples of Cancer Screening
Principles of Cancer Screening
 
Prostate Cancer 2013
Prostate Cancer 2013Prostate Cancer 2013
Prostate Cancer 2013
 
Optimal evaluation of_the_infertile_male
Optimal evaluation of_the_infertile_maleOptimal evaluation of_the_infertile_male
Optimal evaluation of_the_infertile_male
 

More from Chris Merritt

SiMCare Brochure FINAL_Jan 2017
SiMCare Brochure FINAL_Jan 2017SiMCare Brochure FINAL_Jan 2017
SiMCare Brochure FINAL_Jan 2017Chris Merritt
 
VitalSims Brochure_FINAL
VitalSims Brochure_FINALVitalSims Brochure_FINAL
VitalSims Brochure_FINALChris Merritt
 
VitalSims careLearning Press Release
VitalSims careLearning Press ReleaseVitalSims careLearning Press Release
VitalSims careLearning Press Release
Chris Merritt
 
VitalSims
VitalSimsVitalSims
VitalSims
Chris Merritt
 
SiMCare Diabetes
SiMCare DiabetesSiMCare Diabetes
SiMCare Diabetes
Chris Merritt
 
PCMT PowerPoint September 2013
PCMT PowerPoint September 2013PCMT PowerPoint September 2013
PCMT PowerPoint September 2013Chris Merritt
 
PCMT Product Overview April 2013
PCMT Product Overview April 2013PCMT Product Overview April 2013
PCMT Product Overview April 2013Chris Merritt
 

More from Chris Merritt (7)

SiMCare Brochure FINAL_Jan 2017
SiMCare Brochure FINAL_Jan 2017SiMCare Brochure FINAL_Jan 2017
SiMCare Brochure FINAL_Jan 2017
 
VitalSims Brochure_FINAL
VitalSims Brochure_FINALVitalSims Brochure_FINAL
VitalSims Brochure_FINAL
 
VitalSims careLearning Press Release
VitalSims careLearning Press ReleaseVitalSims careLearning Press Release
VitalSims careLearning Press Release
 
VitalSims
VitalSimsVitalSims
VitalSims
 
SiMCare Diabetes
SiMCare DiabetesSiMCare Diabetes
SiMCare Diabetes
 
PCMT PowerPoint September 2013
PCMT PowerPoint September 2013PCMT PowerPoint September 2013
PCMT PowerPoint September 2013
 
PCMT Product Overview April 2013
PCMT Product Overview April 2013PCMT Product Overview April 2013
PCMT Product Overview April 2013
 

Recently uploaded

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 

PCMT Patient Brochure Feb 2013

  • 1. Initial biopsies can miss one-third of all prostate 1 6 men will be out of every cancers. 2 diagnosed with Biopsy needles may not hit small tumors, and biopsy samples may yield inconclusive prostate cancer. 1 results. In both of these situations, no cancer As men age, their risk for getting prostate was found, but it may still exist. Based on cancer increases. However, early detection your medical history and additional risk can help physicians better manage their factors, your doctor may decide to order patients’ health. an additional biopsy. However, in many cases a negative biopsy is truly negative, and a second biopsy is unnecessary. But Screening for how can you and your doctor be more prostate cancer confident in the results? www.mitomicsinc.com Your physician will likely use a digital rectal PCMTsupport@mitomicsinc.com examination and prostate-specific antigen (PSA) test Now there’s an 888.763.2644 to screen for prostate cancer. Irregular or suspicious easy and pain-free results, along with your current health and medical history, may cause your physician to order a What does your Prostate Core Mitomic Test or one or more of its components was developed and its performance characteristics determined prostate biopsy. way to confirm by Mitomics. It has not been approved by the Food and prostate biopsy Drug Administration (FDA). Mitomics has determined that such approval is not necessary. This test is used for clinical Reason for a biopsy biopsy results. purposes. It should not be regarded as investigational or for research. Mitomics is regulated under the Clinical Laboratory Improvement Act (CLIA) of 1988 as qualified to perform high-complexity clinical testing. result really mean? As of today, a biopsy is the only test that fully confirms the diagnosis of prostate cancer. Tissue © 2012-2013 Mitomics Inc. All rights reserved. Prostate Core Mitomic Test, Mitomic, Mitomics, and Empowering samples are taken from your prostate with a needle, Clinical Insight are trademarks of Mitomics Inc. References: 1. American Cancer Society. 2. American Society With the Prostate Core and then analyzed to determine the presence or absence of cancer cells. of Clinical Oncology. Mitomic Test™ now you , 0201.2013 Rev 2 can know.
  • 2. Why should I believe What do the results mean? How do I pay for the Prostate the results of the Prostate Core Mitomic Test? Negative Positive Core Mitomic Test? If you have Medicare, you are responsible for any applicable deductible and co-payment as required Unlike the biopsy, which only examines tissue from by federal insurance regulations. Co-pays are specific areas of the prostate, the Prostate Core 20-percent of the Medicare allowable. Mitomic Test can identify abnormalities in cells that The Prostate are near tumors, not just in the tumors themselves. The Prostate Core Mitomic Test works by recognizing A negative PCMT result A positive PCMT result For commercial insurance, Mitomics accepts the insurer’s contracted allowed amount for the Prostate Core Mitomic Test confirms the negative means you are at a high changes in your mitochondrial DNA. Mitochondria are result of your biopsy. With risk for undiagnosed Core Mitomic Test as payment in full. Please note that structures within a cell that produce energy for the cell. a high degree of certainty, prostate cancer. Your Mitomics is not currently a participating provider with (PCMT™) examines Mitochondrial DNA is highly susceptible to damage. PCMT identifies that you doctor can use this all insurers. If your insurance company denies coverage do not currently have information to tailor The Prostate Core Mitomic Test identifies the damage because Mitomics is out of network, Mitomics will prostate cancer. Because a treatment based on tissue taken from to mitochondrial DNA caused by cellular changes associated with prostate cancer development. an additional biopsy is not your personal situation. work with you directly to appeal the claim. You will be responsible for your normal co-pay, deductibles, and/or your biopsy. You needed, you can avoid By knowing your risk extra pain and anxiety – earlier, you can make co-insurance requirements as identified by your plan. The Prostate Core Mitomic Test is a highly sensitive and have peace of mind more informed decisions do not need to test that can pick out this damage in normal cells that you are prostate concerning your health. The explanation of benefits (EOB) is not a bill. Do not that are adjacent to tumors. As you can see in the cancer free today. make a payment to Mitomics upon receipt of an EOB. have any additional diagram, the cancerous tumor can be quite small, You will be billed in accordance to the billing policy and the biopsy cores may not come in contact with noted above – not the amounts stated on the EOB. When will I receive surgeries or even the tumor. However, the Prostate Core Mitomic Test If you receive insurance proceeds directly, these can identify the presence of the tumor because the the results? proceeds must be forwarded to Mitomics to settle a doctor’s visit. mitochondrial DNA in the tissue throughout the prostate could indicate changes at the cellular level. Your doctor will order the Prostate Core Mitomic the billed amount. Mitomics does not use a collection Test when your biopsy is submitted for evaluation. agency; however, in this circumstance, you will A special lab processes your biopsy tissue, and receive a letter from Mitomics asking that you forward BLADDER the results will be sent to your doctor. Your doctor proceeds to Mitomics. will then contact you to discuss the results. TUMOR PROSTATE If you have any questions concerning billing, health care FIELD EFFECT coverage, or payment for the Prostate Core Mitomic Test, please contact: If you have any questions about BIOPSY CORE GGB Medical Management Services, Inc. the Prostate Core Mitomic Test TUMOR PO Box 2311 or your biopsy results, talk to Chatsworth, CA 91313-2311 your doctor. www.ggbmedical.com 818.718.9519 Spanish URETHRA 800.718.9505 Toll-free 818.718.9507 Fax